In cutaneous lymphoid infiltrates, the presence of a CD5- and CD23-positive B-cell population with a CLL/SLL phenotype supports secondary involvement by systemic leukemia/lymphoma rather than a PCMZL, which more typically shows a plasma cell-rich infiltrate with light-chain restriction. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.